AVDL
Avadel Pharmaceuticals
AVDL
AVDL
Delisted
AVDL was delisted on the 11th of February, 2026.
174 hedge funds and large institutions have $611M invested in Avadel Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 60 increasing their positions, 45 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.93% less ownership
Funds ownership: 82.28% → 80.35% (-1.9%)
27% less capital invested
Capital invested by funds: $833M → $611M (-$222M)
44% less call options, than puts
Call options by funds: $2.25M | Put options by funds: $3.99M
Holders
174
Holding in Top 10
7
Calls
$2.25M
Puts
$3.99M
Top Buyers
| 1 | +$27.4M | |
| 2 | +$8.1M | |
| 3 | +$7.44M | |
| 4 |
TSC
Two Seas Capital
Rye,
New York
|
+$5.09M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$4.7M |
Top Sellers
| 1 | -$43.2M | |
| 2 | -$20.4M | |
| 3 | -$11.1M | |
| 4 |
CC
Checkpoint Capital
San Francisco,
California
|
-$10.6M |
| 5 |
Millennium Management
New York
|
-$8.74M |